The Princeton-based startup said the move was related to “a revenue mix shift within the Noom business" driven by a change in ...

A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...

A randomized controlled trial demonstrated a significantly reduced incidence of type 2 diabetes among individuals with metabolic syndrome who received daily metformin with or without a Mediterranean ...

Many Americans have flocked to cheaper, compounded versions of GLP-1 weight loss drugs in lieu of brand-name treatments. That ...

Shares of Novo Nordisk ( NVO 4.37%) were moving higher on Wednesday. The company's stock gained 4.9% as of 1:50 p.m. ET, but ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

Doctors emphasize the importance of regular checkups with a primary care provider and simple tests that could detect heart ...

The acting deputy attorney general accused FBI leadership of “insubordination” by refusing to identify a “core team” of ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...

Eli Lilly (NYSE:LLY) is scheduled to announce Q4 earnings results on Thursday, February 6th, before market open. The ...

A high-resolution spatial map of the human hypothalamus makes it possible to identify specific cells, determine their exact ...